Investor's Business Daily on MSN7h
Schrodinger Stock Scores IBD Rating UpgradeSchrodinger stock earned a positive adjustment to its Relative Strength (RS) Rating, from 66 to 73. Please watch the video at ...
Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...
SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...
No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
The gut plays a key role in overall health and wellness. Supplements can help fill nutrient gaps to help support beneficial ...
Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a study.
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.
Many of us pay attention to the foods we're putting in our bodies – asking ourselves whether they're nutritious and healthy ...
Many of us pay attention to the foods we're putting in our bodies—asking ourselves whether they're nutritious and healthy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback